Change in Systemic Medication and its Influence on Intraocular Pressure – Results From the Gutenberg Health Study
Use of systemic selective beta-blockers is associated with an IOP change on a population level, whereas the association with other systemic medications on IOP change could be explained by co-medication use or change in blood pressure. Patients undergoing IOP monitoring and management should routinely be asked about changes in systemic medications.
Authors
- Irene Schmidtmann (ORCID: https://orcid.org/0000-0001-8743-6752)
- Esther M. Hoffmann (ORCID: https://orcid.org/0000-0002-0949-4268)
- Philipp S. Wild (ORCID: https://orcid.org/0000-0003-4413-9752)
- Jasmin Ghaemi Kerahrodi (ORCID: https://orcid.org/0000-0003-3789-1583)
- Ida Scholz (ORCID: https://orcid.org/0000-0002-0068-4524)
- Thomas Muenzel (ORCID: https://orcid.org/0000-0001-5503-4150)
- Alica Hartmann (ORCID: https://orcid.org/0000-0002-8721-6036)
- Stavros Konstantinides (ORCID: https://orcid.org/0000-0001-6359-7279)
- Karl J. Lackner (ORCID: https://orcid.org/0000-0002-1985-7931)
- Norbert Pfeiffer (ORCID: https://orcid.org/0000-0002-5766-2617)
- Panagiotis Laspas (ORCID: https://orcid.org/0000-0001-8022-9494)
- Jörn M. Schattenberg (ORCID: https://orcid.org/0000-0002-4224-4703)
- Alexander K. Schuster
- Oliver Tüscher (ORCID: https://orcid.org/0000-0002-4023-5301)
Institutions
- Moorfields Eye Hospital NHS Foundation Trust (GB)
- Johannes Gutenberg University Mainz (DE)
- Leibniz Institute for Resilience Research (DE)
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- German Centre for Cardiovascular Research (DE)
- Institute of Molecular Biology (DE)
- University College London (GB)
Publication Details
- Journal
- Investigative Ophthalmology & Visual Science
- Published
- 2024-12-03
- DOI
- https://doi.org/10.1167/iovs.65.14.4
- Citations
- 1
- Primary Topic
- Glaucoma and retinal disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.54
Funders
- Pfizer
- Sanofi
- Gilead Sciences
- Deutsches Zentrum für Herz-Kreislaufforschung
- Inventiva Pharma
- Intercept Pharmaceuticals
- Apellis Pharmaceuticals
- National Institute for Health and Care Research
- Lister Institute of Preventive Medicine
- Bundesministerium für Bildung und Forschung
- Novo Nordisk
- Santen
- Stiftung Rheinland-Pfalz für Innovation
- Deutsche Ophthalmologische Gesellschaft
- Heidelberg Engineering
- Siemens Healthineers
- Moorfields Eye Hospital NHS Foundation Trust
- Ipsen
- Allergan
- Bayer Vital
- Alcon Research Institute